Alriza 20 Tablet belongs to a class of drugs known as anticoagulants or blood thinner. Alriza 20 Tablet is primarily used to prevent and treat deep vein thrombosis (blood clots in leg veins) and pulmonary embolism (blood clots in the lung) by reducing blood clot formation. Deep vein thrombosis is a medical condition in which blood clots form in deep veins usually in the legs. Pulmonary embolism is a condition in which a blood clot blocks the arteries in the lungs.

Alriza 20 Tablet contains Rivaroxaban, a blood thinner that works by inhibiting the production of clotting factors by decreasing the action of vitamin K. This prevents the conversion of fibrinogen (soluble protein) to fibrin (insoluble protein), thereby preventing blood clots formation.

Take Alriza 20 Tablet as prescribed. You are advised to take Alriza 20 Tablet for as long as your doctor has prescribed it for you depending on your medical conditions. You may experience bleeding, anemia (low number of red blood cells), and nausea. Most of these side effects of Alriza 20 Tablet do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

If you are known to be allergic to Alriza 20 Tablet or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, it is advised to consult a doctor before using Alriza 20 Tablet. If you have a stomach ulcer, kidney or liver problems, high blood pressure, or bleeding problems, inform your doctor before taking Alriza 20 Tablet. Talk to your doctor immediately if you are pregnant or breastfeeding.

Alriza 20 Tablet belongs to a class of drugs known as anticoagulants or blood thinner. Alriza 20 Tablet is primarily used to prevent and treat deep vein thrombosis (blood clots in leg veins) and pulmonary embolism (blood clots in the lung) by reducing blood clot formation. Alriza 20 Tablet works by inhibiting the production of clotting factors by decreasing the action of vitamin K. This prevents the conversion of fibrinogen (soluble protein) to fibrin (insoluble protein), thereby preventing blood clots formation.

Alriza 20 Tablet should be used with caution in children. Prolonged use of Alriza 20 Tablet may cause hair loss. Regular blood tests are recommended while taking Alriza 20 Tablet to check the time taken for your blood to clot and the level of platelets (blood cells). If you are known to be allergic to Alriza 20 Tablet or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, it is advised to consult a doctor before using Alriza 20 Tablet. If you have a stomach ulcer, kidney or liver problems, high blood pressure, or bleeding problems, inform your doctor before taking Alriza 20 Tablet. Talk to your doctor immediately if you are pregnant or breastfeeding.

• Avoid making any changes in your diet without first talking to your doctor.
• Cranberry juice, grapefruit juice, noni juice, and pomegranate juice may interact with Alriza 20 Tablet and lead to unwanted side effects. Hence try to avoid these juices while taking Alriza 20 Tablet.
• Avoid drinking alcohol as it increases the risk of gastrointestinal ulcer/bleeding.

You should have regular platelet count, factor V assay, fibrinogen level test, prothrombin time test (PT or PT-INR) and the INR, or international normalized ratio to analyze your blood clotting time.

Deep vein thrombosis (blood clots in legs) is a medical condition in which blood clots form in deep veins usually in the legs. The symptoms include leg pain or swelling. Pulmonary embolism (blood clots in the lung) is a chronic condition that occurs as the blood clots break and travel to the lungs from deep veins in the legs or other parts of the body. The symptoms of pulmonary embolism include cough, chest pain, and shortness of breath.